Co-Production and Patient Preferences

CautionSpeculation: Co-Production as a Healthcare Design Principle

A 2025 co-production study — in which ME/CFS patients collaborated with researchers to design care services — identified patient preferences for multidisciplinary teams, mHealth tools for symptom tracking and communication, and care pathways that respect energy limitations (Thornton et al. 2025). The study’s small sample (n = 8) limits generalizability, but the methodology — designing services with patients rather than for them — represents an approach that health-services research increasingly recognizes as essential for chronic disease care design. (Certainty: 0.50 — small qualitative; co-production methodology is sound but generically applicable; no ME/CFS-specific validation. Falsifiable prediction: ME/CFS care services designed via co-production will show higher patient retention and satisfaction than services designed without patient input.)

Consequence: If co-production improves service design for chronic diseases generally, and ME/CFS patients have specific needs (energy-limited communication, multidisciplinary coordination, PEM-aware appointment scheduling) that standard care models fail to meet, then co-produced service design may be the most efficient route to closing the gap between what patients need and what healthcare systems deliver. The hypothesis is plausible but untested in ME/CFS specifically. Severity applicability: co-production is most important for severe/very severe patients (whose needs are least visible to clinic-based designers), but the methodology applies to all severity levels. For a systematic treatment of patient-researcher co-production across the research lifecycle — from study design to interpretation — see Patient-Generated Knowledge and Citizen Science.

NoteClinical Finding: Severe-Care Advocacy Favors a Single Point of Contact Over Multidisciplinary Teams

The patient-preference evidence above (Co-Production as a Healthcare Design Principle) reports a preference for multidisciplinary teams — but a major severe-ME/CFS clinical-advocacy source takes the opposite position. The Science for ME (2026) factsheet on managing severe and very-severe ME/CFS, authored by Prof. Jonathan Edwards and S4ME members, argues that multidisciplinary teams of professionals assigned to different aspects of care are likely to be counterproductive for this population Science for ME (2026). It recommends instead a single point of contact — “a specialist nurse with a deep understanding of the current state of knowledge about ME/CFS” — who provides a fixed reference around which the patient builds a sense of context and safety, ideally liaising directly with a physician involved in initial assessment and diagnosis Science for ME (2026). The rationale is that a housebound, bedbound, or severely sensory-sensitive patient cannot tolerate the repeated, fragmented, and stimulus-rich contact that a multidisciplinary roster imposes; a single trusted professional can batch care acts and coordinate domiciliary services.

These two positions are not directly contradictory on mechanism: the co-production study reflects the preferences of predominantly less-severe, clinic-able participants, whereas the factsheet speaks specifically to the severe/very-severe subset who cannot attend clinics and for whom every visit is a PEM risk. The tension — multidisciplinary team vs single point of contact — may itself be severity-stratified. No comparative study has tested either model in severe ME/CFS; both rest on expert opinion and patient-experience evidence. (Certainty: 0.40 — expert-consensus/advocacy + small qualitative preference study; no comparative effectiveness data. Severity applicability: severe/very-severe — the factsheet’s single-point-of-contact recommendation targets this subset specifically.)

Limitations: Both positions are advocacy/consensus or small-sample qualitative, with zero comparative effectiveness data; the factsheet’s single-contact recommendation is UK-context expert opinion and may not transfer to other health systems; the severity-stratified resolution is a reasonable interpretation, not a tested finding.

Consequence: For health-system planners designing severe-ME/CFS care, this is a live design fork with no evidence to arbitrate it: a multidisciplinary roster risks overwhelming the most severely affected patient, while a single contact risks concentrating too much responsibility in one under-resourced professional. The severity-stratified interpretation — multidisciplinary for ambulatory patients, single-contact for housebound/bedbound — is a reasonable working hypothesis but remains untested.

References

Science for ME. 2026. “Management of Severe and Very Severe ME/CFS.” Science for ME (S4ME) fact sheet. https://www.s4me.info/.
Thornton, Emily J., Lawrence D. Hayes, Daniel S. Goodwin, Nicholas Sculthorpe, Yeliz Prior, and Nilihan E. M. Sanal-Hayes. 2025. “Managing Energy, and Shaping Care: Insights from Adults with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Through Co-Production Workshops.” American Journal of Medicine 138 (6): 1001–9. https://doi.org/10.1016/j.amjmed.2025.02.008.